Levothyroxine Sodium (Synthroid)

Trade Name : Synthroid

AbbVie Inc.

TABLET

Strength 137 ug/1

LEVOTHYROXINE SODIUM l-Thyroxine [EPC],Thyroxine [CS]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Levothyroxine Sodium (Synthroid) which is also known as Synthroid and Manufactured by AbbVie Inc.. It is available in strength of 137 ug/1 per ml. Read more

Levothyroxine Sodium (Synthroid) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • WARNING: NOT FOR TREATMENT OF OBESITY OR FOR WEIGHT LOSS
  • See full prescribing information for complete boxed warning
  • Thyroid hormones, including SYNTHROID should not be used for the treatment of obesity or for weight loss.
  • Doses beyond the range of daily hormonal requirements may produce serious or even life threatening manifestations of toxicity , .
  • Hypothyroidism
  • SYNTHROID is indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.
  • Pituitary Thyrotropin (Thyroidu2011Stimulating Hormone, TSH) Suppression
  • SYNTHROID is indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.
  • SYNTHROID is levothyroxine sodium (T4) indicated for:
  • Limitations of Use:
  • No data
  • Administer once daily, preferably on an empty stomach, one-half to one hour before breakfast.n
  • Administer at least 4 hours before or after drugs that are known to interfere with absorption. n
  • Evaluate the need for dose adjustments when regularly administering within one hour of certain foods that may affect absorption. n
  • Starting dose depends on a variety of factors, including age, body weight, cardiovascular status, and concomitant medications. Peak therapeutic effect may not be attained for 4-6 weeks. n
  • See full prescribing information for dosing in specific patient populations. n
  • Adequacy of therapy determined with periodic monitoring of TSH and/or T4 as well as clinical status. n
  • SYNTHROID tablets are available as follows:
  • Tablets: u00a025, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200, and 300 mcg n
  • SYNTHROID is contraindicated in patients with uncorrected adrenal insufficiency .
  • Uncorrected adrenal insufficiency. n
  • No data
  • Cardiac adverse reactions in the elderly and in patients with underlying cardiovascular disease:
  • Myxedema coma:
  • Acute adrenal crisis in patients with concomitant adrenal insufficiency:
  • Prevention of hyperthyroidism or incomplete treatment of hypothyroidism:
  • Worsening of diabetic control:
  • Decreased bone mineral density associated with thyroid hormone over-replacement:
  • Adverse reactions associated with SYNTHROID therapy are primarily those of hyperthyroidism due to therapeutic overdosage , . They include the following:
  • Seizures have been reported rarely with the institution of levothyroxine therapy.
  • Adverse reactions associated with SYNTHROID therapy are primarily those of hyperthyroidism due to therapeutic overdosage: arrhythmias, myocardial infarction, dyspnea, muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite, weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash. n n n
  • To report SUSPECTED ADVERSE REACTIONS, contact AbbVie Inc. at 1-800-633-9110 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • See full prescribing information for drugs that affect thyroid hormone pharmacokinetics and metabolism (e.g., absorption, synthesis, secretion, catabolism, protein binding, and target tissue response) and may alter the therapeutic response to SYNTHROID. n
  • Pregnancy may require the use of higher doses of SYNTHROID. , n
  • The signs and symptoms of overdosage are those of hyperthyroidism and. In addition, confusion and disorientation may occur. Cerebral embolism, shock, coma, and death have been reported. Seizures occurred in a 3-year-old child ingesting 3.6 mg of levothyroxine. Symptoms may not necessarily be evident or may not appear until several days after ingestion of levothyroxine sodium.
  • Reduce the SYNTHROID dose or discontinue temporarily if signs or symptoms of overdosage occur. Initiate appropriate supportive treatment as dictated by the patientu2019s medical status.
  • For current information on the management of poisoning or overdosage, contact the National Poison Control Center at 1-800-222-1222 or www.poison.org.
  • SYNTHROID (levothyroxine sodium tablets, USP) contain synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is chemically identical to that produced in the human thyroid gland. Levothyroxine (T4) sodium has an empirical formula of CHIN NaOu2022 HO, molecular weight of 798.86 (anhydrous), and structural formula as shown:
  • SYNTHROID tablets for oral administration are supplied in the following strengths: 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200 mcg, and 300 mcg. Each SYNTHROID tablet contains the inactive ingredients acacia, confectioner's sugar (contains corn starch), lactose monohydrate, magnesium stearate, povidone, and talc. SYNTHROID tablets contain no ingredients made from a gluten-containing grain (wheat, barley, or rye). Each tablet strength meets USP Dissolution Test 3. Table 6 provides a listing of the color additives by tablet strength:
  • No data
  • Standard animal studies have not been performed to evaluate the carcinogenic potential, mutagenic potential or effects on fertility of levothyroxine.
  • SYNTHROID (levothyroxine sodium, USP) tablets are supplied as follows:
  • Storage Conditions
  • Store at 25u00b0C (77u00b0F); excursions permitted to 15u00b0 to 30u00b0 C (59u00b0 to 86u00b0 F)
  • [see USP Controlled Room Temperature]. SYNTHROID tablets should be protected from light and moisture.
  • Arrayn- Array
  • Dosing and Administration
  • Important Information
  • Adverse Reactions
  • u00a9 2018 AbbVie Inc.
  • AbbVie Inc.
  • North Chicago, IL 60064, U.S.A.
  • 03-B792 November 2018
  • NDC 0074-4552-11
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 50 mcg (0.05 mg)
  • 100 Tablets
  • THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
  • Rx only abbvie
  • NDC 0074-6624-11
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 100 mcg (0.1 mg)
  • 100 Tablets
  • THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
  • Rx only abbvie
  • NDC 0074-7148-11
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 200 mcg (0.2 mg)
  • 100 Tablets
  • THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
  • Rx only abbvie
  • NDC 0074-3727-90
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 137 mcg (0.137 mg)
  • 90 Tablets
  • Rx only abbvie
  • NDC 0074-4341-19
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 25 mcg (0.025 mg)
  • 1000 Tablets
  • Rx only abbvie
  • NDC 0074-5182-19
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 75 mcg (0.075 mg)
  • 1000 Tablets
  • Rx only abbvie
  • NDC 0074-6594-90
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 88 mcg (0.088 mg)
  • 90 Tablets
  • Rx only abbvie
  • NDC 0074-7068-19
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 125 mcg (0.125 mg)
  • 1000 Tablets
  • Rx only abbvie
  • NDC 0074-7069-90
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 150 mcg (0.15 mg)
  • 90 Tablets
  • Rx only abbvie
  • NDC 0074-7070-19
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 175 mcg (0.175 mg)
  • 1000 Tablets
  • Rx only abbvie
  • NDC 0074-7149-90
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 300 mcg (0.3 mg)
  • 90 Tablets
  • Rx only abbvie
  • NDC 0074-9296-19
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 112 mcg (0.112 mg)
  • 1000 Tablets
  • Rx only abbvie
  • NDC 0074-4341-72
  • 2 cards x 7 tablets
  • orange 25mcg (0.025mg) Synthroid
  • Synthroid u00ae
  • levothyroxine sodium tablets, USP
  • www.synthroid.com
  • THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
  • Professional sample. Not for sale. Rx only abbvie
  • NDC 0074-4552-90
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 50 mcg
  • (0.05mg)
  • 90 Tablets
  • Rx only abbvie
  • NDC 0074-5182-72 2 cards x 7 tablets
  • violet 75 mcg (0.075 mg) Synthroid
  • Synthroidu00ae
  • levothyroxine sodium tablets, USP
  • www.synthroid.com
  • THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
  • Professional sample. Not for sale. Rx only abbvie
  • NDC 0074-9296-72 2 cards x 7 tablets
  • rose 112mcg (0.112 mg) Synthroid
  • Synthroidu00ae
  • levothyroxine sodium tablets, USP
  • www.synthroid.com
  • THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
  • Professional sample. Not for sale. Rx only abbvie
  • NDC 0074-7148-90
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 200 mcg
  • (0.2 mg)
  • 90 Tablets
  • Rx only abbvie
  • NDC 0074-6624-72 2 cards x 7 tablets
  • yellow 100 mcg (0.1mg) Synthroid
  • Synthroidu00ae
  • levothyroxine sodium tablets, USP
  • www.synthroid.com
  • THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
  • Professional sample. Not for sale. Rx only abbvie
  • NDC 0074-6624-90
  • Synthroidn
  • Levothyroxine Sodium Tablets, USP
  • 100 mcg
  • (0.1 mg)
  • 90 Tablets
  • Rx only abbvie

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.